Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > $3.5% ROYALTY TO THE CRO
View:
Post by Jkj193741 on Jun 22, 2021 3:40pm

$3.5% ROYALTY TO THE CRO

Anyone, DID I HEAR THAT CORRECTLY? PLUS NO QUESTIONS ALLOWED AT A AGM?Thx jk
Comment by archman on Jun 22, 2021 4:01pm
I was only listening sporatically - but heard that Eversana had modeled receipts from this deal over the inital 5 year of one-quarter of a billion.  That would be over $7 biillion in sales (USD assumed).  
Comment by Jkj193741 on Jun 22, 2021 5:32pm
THANKS ARCHMAN. JK